N🟁N

Market Maker Surveillance Report. IVAN, CRME, DEXO, AAU, FMCKJ, ZGNX, Winning Stocks With Lowest Price Friction For Thursday,

December 29, 2011 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 3807 companies with "abnormal" market making, 4227 companies with positive Friction Factors and 2366 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Thursday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. IVANHOE ENERGY INC (NASDAQ:IVAN), CARDIOME PHARMA CORP (NASDAQ:CRME), DEX ONE CORP (NYSE:DEXO), ALMADEN MINERALS LTD (AMEX:AAU), FEDERAL HOME LOAN MORTGAGE CORPORATION (OTC:FMCKJ), ZOGENIX INC (NASDAQ:ZGNX). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

     Symbol     Change       Percent      Buy Volume      Buy %%       Sell Volume     Sell %%      Net Volume      Friction
     IVAN       $0.160       15.69%       1,742,231       56.83%       1,324,221       43.19%       418,010         26,126  
     CRME       $0.390       17.35%       662,605         55.56%       519,300         43.55%       143,305         3,674   
     DEXO       $0.260       16.99%       1,672,211       37.75%       1,387,934       31.33%       284,277         10,934  
     AAU        $0.310       14.36%       104,175         36.17%       89,952          31.23%       14,223          459     
     FMCKJ      $0.170       13.60%       1,936,515       97.43%       51,075          2.57%        1,885,440       110,908 
     ZGNX       $0.940       44.76%       539,930         58.09%       389,466         41.91%       150,464         1,601   

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows IVAN with a dollar gain Thursday of $0.16000 and a Friction Factor of 26,126 shares. That means that it only took 26,126 more shares of buying than selling to move IVAN higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.

IVANHOE ENERGY INC (NASDAQ:IVAN) - Ivanhoe Energy Inc., an independent heavy oil development and production company, engages in the development and production of oil and gas properties. Its principal oil and gas properties are located in the Hebei and Sichuan Provinces in China. The companys integrated oil and gas properties include the Tamarack project located in the Athabasca oil sands region in the Province of Alberta, Canada; and the Ecuador project located in Quito, Ecuador. It also owns a nonexclusive master license entitling it to use GTL Technology to convert natural gas into transportation fuels and other synthetic petroleum products. GTL process is designed to catalytically convert natural gas into synthetic liquid hydrocarbons. The company was formerly known as Black Sea Energy Ltd. and changed its name to Ivanhoe Energy Inc. in June 1999. Ivanhoe Energy was founded in 1995 and is based in Vancouver, Canada.

CARDIOME PHARMA CORP (NASDAQ:CRME) - Cardiome Pharma Corp., a life sciences company, engages in developing proprietary drugs to treat or prevent cardiovascular and other diseases. The company offers BRINAVESS, a product approved for marketing in the European Union, Iceland, and Norway for the conversion of recent onset atrial fibrillation to sinus rhythm in adults. It also has clinical programs, which focuses on the treatment of atrial fibrillation, an arrhythmia (or abnormal rhythm) of the upper chambers of the heart. The company has a phase 1 program for GED-aPC, an engineered analog of recombinant human activated Protein C that completed phase I clinical trials for the treatment of infectious disease. In addition, Cardiome Pharma Corp. has pre-clinical projects that focus on cardiac diseases, ion channel conditions, and other indications. It also has a collaboration and license agreement with Merck & Co., Inc. (Merck), for the development and commercialization of vernakalant; and Astellas Pharma US, Inc. to develop, make, and sell intravenous or injectable formulations of vernakalant in North America. The company was formerly known as Nortran Pharmaceuticals Inc. and changed its name to Cardiome Pharma Corp. in June 2001. Cardiome Pharma Corp. was founded in 1986 and is headquartered in Vancouver, Canada.

DEX ONE CORP (NYSE:DEXO) - Dex One Corporation operates as a marketing solutions company. The company offers various marketing solutions to promote businesses on the Internet, such as assessment of marketing programs and advertisements, message and image creation, recommendations for advertising placement, industry-specific research and information, market-specific research and information, in-depth understanding of how consumers search for businesses and what influences them to buy from one business versus another, Dex published yellow pages, Dex published white pages, search engine optimization strategies, keyword implementation, social strategies, and tracking and reporting. It also provides printed yellow pages directories, including core directories, community directories, and plus companion directories to meet the advertising needs of local and national businesses and the informational needs of local consumers. In addition, the company offers online products and services comprising Dexknows.com, which allows the user to search based on a category, business name, or set of keyword terms within a geographic region, as well as provides users to refine their searches, such as specific product and brand names, hours of operation, payment options, and locations; and DexNet for the placement of clients business listings in prime locations on DexKnows.com. Further, it provides other marketing solutions, such as local business and market analysis, target market identification, advertising and digital profile creation, and distribution strategies. The company was formerly known as R.H. Donnelley Corporation and changed its name to Dex One Corporation in January 2010. Dex One Corporation was founded in 1841 and is headquartered in Cary, North Carolina.

ALMADEN MINERALS LTD (AMEX:AAU) - Almaden Minerals Ltd., an exploration stage company, engages in the acquisition, exploration, and development of mineral properties in Canada, the United States, and Mexico. It principally holds interests in the Elk gold and silver property comprising the Siwash Gold deposit in Canada; and Caballo Blanco gold, silver, and copper prospect consisting of 8,200 hectares located in the state of Veracruz, Mexico. The company was founded in 1980 and is headquartered in Vancouver, Canada.

FEDERAL HOME LOAN MORTGAGE CORPORATION (OTC:FMCKJ) -

ZOGENIX INC (NASDAQ:ZGNX) - Zogenix, Inc., a pharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system disorders and pain. The companys principal commercial product includes SUMAVEL DosePro (sumatriptan injection) Needle-free Delivery System for the acute treatment of migraine and cluster headache. It also offers ZX002, a novel, oral, single-entity controlled-release formulation of hydrocodone that is in Phase 3 clinical trials for the treatment of moderate to severe chronic pain in patients requiring around-the-clock opioid therapy. In December 2010, the company received approval from the Danish Medicines Agency of Denmark for the Marketing Authorization Application for SUMAVEL DosePro Needle-Free Delivery System. Zogenix, Inc. was founded in 2006 and is based in San Diego, California.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net